Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The SARS-CoV-2 Lambda variant exhibits enhanced infectivity and immune resistance
Izumi Kimura, Yusuke Kosugi, Jiaqi Wu, et al.
Cell Reports (2021) Vol. 38, Iss. 2, pp. 110218-110218
Open Access | Times Cited: 181

Showing 1-25 of 181 citing articles:

Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity
Bo Meng, Adam Abdullahi, Isabella A. T. M. Ferreira, et al.
Nature (2022) Vol. 603, Iss. 7902, pp. 706-714
Open Access | Times Cited: 976
Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5
Qian Wang, Yicheng Guo, Sho Iketani, et al.
Nature (2022) Vol. 608, Iss. 7923, pp. 603-608
Open Access | Times Cited: 714
Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation
Akatsuki Saito, Takashi Irie, Rigel Suzuki, et al.
Nature (2021) Vol. 602, Iss. 7896, pp. 300-306
Open Access | Times Cited: 554
Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike
Daichi Yamasoba, Izumi Kimura, Hesham Nasser, et al.
Cell (2022) Vol. 185, Iss. 12, pp. 2103-2115.e19
Open Access | Times Cited: 313
Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants
Tomokazu Tamura, Jumpei Ito, Keiya Uriu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 262
Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.4 and BA.5
Izumi Kimura, Daichi Yamasoba, Tomokazu Tamura, et al.
Cell (2022) Vol. 185, Iss. 21, pp. 3992-4007.e16
Open Access | Times Cited: 243
Neutralisation sensitivity of SARS-CoV-2 omicron subvariants to therapeutic monoclonal antibodies
Daichi Yamasoba, Yusuke Kosugi, Izumi Kimura, et al.
The Lancet Infectious Diseases (2022) Vol. 22, Iss. 7, pp. 942-943
Open Access | Times Cited: 197
Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant
Akatsuki Saito, Tomokazu Tamura, Jiří Zahradník, et al.
Cell Host & Microbe (2022) Vol. 30, Iss. 11, pp. 1540-1555.e15
Open Access | Times Cited: 152
Convergent evolution of SARS-CoV-2 Omicron subvariants leading to the emergence of BQ.1.1 variant
Jumpei Ito, Rigel Suzuki, Keiya Uriu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 121
Mapping SARS-CoV-2 antigenic relationships and serological responses
Samuel Wilks, Barbara Mühlemann, Xiaoying Shen, et al.
Science (2023) Vol. 382, Iss. 6666
Open Access | Times Cited: 100
SARS-CoV-2: Evolution and Emergence of New Viral Variants
Verónica Roxana Flores-Vega, Jessica Viridiana Monroy-Molina, Luis Enrique Jiménez-Hernández, et al.
Viruses (2022) Vol. 14, Iss. 4, pp. 653-653
Open Access | Times Cited: 89
Emerging Vaccine-Breakthrough SARS-CoV-2 Variants
Rui Wang, Jiahui Chen, Yuta Hozumi, et al.
ACS Infectious Diseases (2022) Vol. 8, Iss. 3, pp. 546-556
Open Access | Times Cited: 73
SARS-CoV-2 Omicron sublineages exhibit distinct antibody escape patterns
Henning Gruell, Kanika Vanshylla, Michael Korenkov, et al.
Cell Host & Microbe (2022) Vol. 30, Iss. 9, pp. 1231-1241.e6
Open Access | Times Cited: 71
Virological characteristics of the SARS-CoV-2 BA.2.86 variant
Tomokazu Tamura, Keita Mizuma, Hesham Nasser, et al.
Cell Host & Microbe (2024) Vol. 32, Iss. 2, pp. 170-180.e12
Open Access | Times Cited: 63
Natural triterpenoids from licorice potently inhibit SARS-CoV-2 infection
Yi Yang, Junhua Li, Xinyuan Lai, et al.
Journal of Advanced Research (2021) Vol. 36, pp. 201-210
Open Access | Times Cited: 91
Virological characteristics of SARS-CoV-2 BA.2 variant
Daichi Yamasoba, Izumi Kimura, Hesham Nasser, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 63
A review on evolution of emerging SARS-CoV-2 variants based on spike glycoprotein
Nimisha Ghosh, Suman Nandi, Indrajit Saha
International Immunopharmacology (2022) Vol. 105, pp. 108565-108565
Open Access | Times Cited: 61
Mapping SARS-CoV-2 antigenic relationships and serological responses
Samuel Wilks, Barbara Mühlemann, Xiaoying Shen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 60
A spatiotemporally resolved infection risk model for airborne transmission of COVID-19 variants in indoor spaces
Xiangdong Li, Daniel Lester, Gary Rosengarten, et al.
The Science of The Total Environment (2021) Vol. 812, pp. 152592-152592
Open Access | Times Cited: 59
Schaftoside inhibits 3CLpro and PLpro of SARS-CoV-2 virus and regulates immune response and inflammation of host cells for the treatment of COVID-19
Yi Yang, Meng Zhang, Heng Xue, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 11, pp. 4154-4164
Open Access | Times Cited: 55
Will the COVID-19 pandemic end with the Delta and Omicron variants?
Chaoqi Wang, Jie Han
Environmental Chemistry Letters (2022) Vol. 20, Iss. 4, pp. 2215-2225
Open Access | Times Cited: 49
The SARS-CoV-2 spike S375F mutation characterizes the Omicron BA.1 variant
Izumi Kimura, Daichi Yamasoba, Hesham Nasser, et al.
iScience (2022) Vol. 25, Iss. 12, pp. 105720-105720
Open Access | Times Cited: 48
SARS-CoV-2 Omicron spike mediated immune escape and tropism shift
Ravindra K. Gupta
Research Square (Research Square) (2022)
Open Access | Times Cited: 47
Virological characteristics of the novel SARS-CoV-2 Omicron variants including BA.2.12.1, BA.4 and BA.5
Izumi Kimura, Daichi Yamasoba, Tomokazu Tamura, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 47
A circular mRNA vaccine prototype producing VFLIP-X spike confers a broad neutralization of SARS-CoV-2 variants by mouse sera
Chotiwat Seephetdee, Kanit Bhukhai, Nattawut Buasri, et al.
Antiviral Research (2022) Vol. 204, pp. 105370-105370
Open Access | Times Cited: 44
Page 1 - Next Page

Scroll to top